albuterol has been researched along with Diseases of Immune System in 3 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ryle, PR | 1 |
| Herzyk, DJ | 1 |
| Tiegs, G | 1 |
| Bang, R | 1 |
| Neuhuber, WL | 1 |
1 review available for albuterol and Diseases of Immune System
| Article | Year |
|---|---|
Justification for routine screening of pharmaceutical products in immune function tests: a review of the recommendations of Putman et al. (2003).
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Buprenorphine; Drug Evaluation, Preclinical; Drug-Rela | 2005 |
2 other studies available for albuterol and Diseases of Immune System
| Article | Year |
|---|---|
Assessing immunotoxicity of pharmaceuticals: the need for enhanced testing.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Drug-Related Side Effects and Adverse Reactions; Human | 2005 |
Requirement of peptidergic sensory innervation for disease activity in murine models of immune hepatitis and protection by beta-adrenergic stimulation.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Capsaicin; Catecholamines; Hepatitis, Animal; Immune S | 1999 |